Literatur
Raina DB, Isaksson H, Hettwer W, Kumar A, Lidgren L, Tägil M (2016) A biphasic calcium sulphate/hydroxyapatite carrier containing bone morphogenic protein‑2 and zoledronic acid generates bone. Sci Rep 6:26033
Raina DB, Matuszewski LM, Vater C, Bolte J, Isaksson H, Lidgren L, Tägil M, Zwingenberger S (2020) A facile one-stage treatment of critical bone defects using a calcium sulfate/hydroxyapatite biomaterial providing spatiotemporal delivery of bone morphogenic protein‑2 and zoledronic acid. Sci Adv 6(48):eabc1779
McNally MA, Ferguson JY, Lau AC, Diefenbeck M, Scarborough M, Ramsden AJ, Atkins BL (2016) Single-stage treatment of chronic osteomyelitis with a new absorbable, gentamicin-loaded, calcium sulphate/hydroxyapatite biocomposite: a prospective series of 100 cases. Bone Joint J 98-B(9):1289–1296
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
M. Diefenbeck ist Angestellter der Fa. Bonesupport GmbH und besitzt Aktien und Aktienoptionen der Firma.
Additional information
Die Autoren des Originalbeitrags verzichten auf eine Replik zu diesem Leserbrief.
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Diefenbeck, M. Knochenersatzstoffe und segmentale Knochendefekte. Unfallchirurgie 125, 921–922 (2022). https://doi.org/10.1007/s00113-022-01246-0
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00113-022-01246-0